Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million ...

UCSF researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to ...

These cases illustrate scenarios where final pathology often reveals a higher risk of recurrence than anticipated, requiring ...

At the ESMO Annual Meeting 2025, experts urge governments to make workforce training a political priority, calling it key to ...

Total revenues of $1.37 billion in the third quarter of 2025, reflecting 20% growth compared to the third quarter of 2024 ...

Robblee also acts as deputy director for Community Outreach and Engagement at the Montefiore Einstein Comprehensive Cancer Center and is a professor in the departments of Epidemiology and Population ...

Disrupted sleep is a common, often overlooked problem for pediatric patients being treated for acute lymphoblastic leukemia (ALL). To address this issue, researchers at Dana-Farber/Boston Children's ...

Pediatric cancer foundation Cal's Angels has donated $4 million to establish a program aimed at improving outcomes for young ...

Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...

Courtesy Four Seasons Resort Four Seasons Resort Orlando at Walt Disney World Resort once again proved that luxury and ...

CHAPEL HILL, N.C. (WTVD) -- Some of the nation's leading medical experts and oncologists convened onto the campus of UNC ...

Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...